Just Ad

PRESS RELEASE FOR IASIS PHARMA PARTICIPATION IN THE TWO-DAY CONFERENCE OF THE GREEK ASSOCIATION OF ALZHEIMER’S DISEASE AND RELATED DISORDERS (ALZHEIMER HELLAS)

Just Ad 2016-09-26T12:59:13+00:00 28/09/2014|All articles, Press Room|

KEDEA HALL OF THE ARISTOTLE UNIVERSITY OF THESSALONIKI, 19-20/09/2014 The Greek Association of Alzheimer’s Disease in cooperation with the Angelopoulos Foundation, the ΑSPAD and ΕνΝΟΗΣΗΣ research programs of the AUT and the PanHellenic Institute of Neurodegenerative Diseases organized a scientific conference under the title: “Moral Dilemmas and New Technologies in the treatment of Dementia” that took place [...]

LICOSIL PRESS RELEASE

Just Ad 2016-09-26T13:02:03+00:00 08/09/2014|All articles, Product launches|

Pharma Q, a member of IASIS PHARMA group of companies, has launched a new pharmaceutical product under the brand name Licosil (Sildenafil) to treat erectile dysfunction. Licosil is the 1st generic sildenafil, which has been successfully launched in the Greek pharmaceutical market by a Greek pharmaceutical industry in τwο strengths: 50 and 100 mg respectively [...]

PRESS RELEASE – IASIS PHARMA PARTICIPATION IN THE SUMMER DAY CONFERENCE OF EDAE

Just Ad 2016-09-26T14:07:42+00:00 27/06/2014|All articles, Press Room|

DIVANI CARAVEL HOTEL, ATHENS, 21/06/2014 IASIS PHARMA participated, as it consistently does every year, in the Annual Summer Day Conference of the Hellenic Society of Dermatology and Venereology that took place at the DIVANI CARAVEL HOTEL Athens, on 21 June 2014. IASIS PHARMA has a strong and long-lasting relation with the field of Dermatology and has [...]

LARTOKAZ PRESS RELEASE

Just Ad 2016-09-26T14:10:08+00:00 19/05/2014|All articles, Product launches|

IASIS PHARMA has launched a new pharmaceutical product under the brand name Lartokaz. It is an Irbesartan/hydrochlorothiazide combination preparation in two strengths: (150+12,5)mg/tab and (300+12,5)mg/tab respectively. Irbesartan is an angiotensin II receptor antagonist used mainly for the treatment of hypertension and in a combination formulation with hydrochlorothiazide(diuretic), is able to achieve an additive antihypertensive effect.

RABEREN/ΙΑSIS PRESS RELEASE

Just Ad 2016-09-26T14:24:45+00:00 28/04/2014|All articles, Product launches|

IASIS PHARMA has launched a new pharmaceutical product under the brand name Raberen (as rabeprazole sodium). Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. Raberen in either 10 or 20 mg form of gastro-resistant tablets, is the 1st generic rabeprazole, which has been successfully launched in the Greek pharmaceutical market by [...]

PRESS RELEASE – IASIS PHARMA PARTICIPATION IN THE SPRING DAY CONFERENCE OF EDAE

Just Ad 2016-09-26T15:49:31+00:00 16/04/2014|All articles, Press Room|

HYATT REGENCY HOTEL, THESSALONIKI, 12/04/2014 IASIS PHARMA participated, as it consistently does every year, in the Annual Spring Day Conference of the Hellenic Society of Dermatology and Venereology that took place at the HYATT REGENCY HOTEL Thessaloniki, on 12 April 2014. IASIS PHARMA stand was visited by a high number of Dermatologists where three (3) of its [...]

CONTRAHIST PRESS RELEASE

Just Ad 2016-09-26T15:53:47+00:00 02/04/2014|All articles, Product launches|

IASIS PHARMA has launched a new pharmaceutical product under the brand name Contrahist (as levocetirizine dihydrochloride). It is a non-sedative antihistamine and is available as 5 mg-strength f.c tablets and a 0.5 mg/mL oral solution. Contrahist is the 1st generic levocetirizine, which has been successfully launched in the Greek pharmaceutical market by a Greek pharmaceutical [...]

PRESS RELEASE FOR IASIS PHARMA PARTICIPATION IN THE 19TH HELLENIC CONFERENCE FOR HELICOBACTER PYLORI AND OTHER INFECTIONS OF THE PEPTIC SYSTEM

Just Ad 2016-09-26T16:06:26+00:00 21/03/2014|All articles, Press Room|

BIOMEDICAL RESEARCH FOUNDATION AMPITHEATRE, ATHENS, 15/03/2014 IASIS PHARMA successfully participated in the 19th Hellenic Conference for Helicobacter Pylori and Other Infections of the Peptic System that took place at the amphitheater of the Biomedical research Foundation, Athens, 15 March 2014, organized by the Hellenic Society for the Study of H pylori. Congress invitees included distinguished gastroenterologists [...]

LICEPLER PRESS RELEASE

Just Ad 2016-09-26T16:14:58+00:00 17/03/2014|All articles, Product launches|

IASIS PHARMA has launched a new pharmaceutical product under the brand name Licepler (Eplerenone). Licepler is specifically indicated for the reduction of risk of cardiovascular death in people with heart failure and left ventricular dysfunction ≤40% after a recent acute myocardial infarction, in combination with standard therapies and as treatment against hypertension. Licepler (25mg/f.c. tab [...]

VENLAXIN PRESS RELEASE

Just Ad 2016-09-26T16:17:08+00:00 14/02/2014|All articles, Product launches|

IASIS PHARMA has launched a new pharmaceutical product under the brand name Venlaxin. The active ingredient of Venlaxin is venlafaxine, approved for the treatment of MajorDepressive Disorder. Venlaxin prolonged release tablets (PR tabs) utilize a unique osmotic tablet technology to specifically address the once daily delivery of the drug. This unique osmotic tablet technology allows [...]

"There is no field so impregnable for him that works with soul,
nor field for sure for him that works without a soul"
Alexander the Great

About Just Ad